administration of oxytocin causes tail skin temperatures to drop within 1 h of administration, while temperatures of rats injected with saline remain increased for about 2 h. 6 Previous studies have demonstrated a reduced motor activity 8, 9 and stress states 9 following the peripheral administration of oxytocin at a high dose (1 mg/kg, s.c.). An increase in metabolism and core temperatures has been demonstrated following central administration. 7 However, when a lower dose (0.1 mg/kg, s.c.) is administered male rats shift their activity from the periphery to the center of an open field, behaviour which is viewed as a sign of anxiolysis. 8 Also, estrogen-primed female mice given oxytocin have been found to demonstrate anxiolysis by an increase in the proportion of time spent in the open arms of an elevated plus-maze. 10 Oxytocin may thus dosedependently elicit both stress and anti-stress effects.
Recently, it has been suggested that the olfactory bulb is a critical site of oxytocin action with regards to gating of aversive stimulation, inducing stress reduction in the context of mother-offspring interactions. [11] [12] [13] [14] Incidental observations of altered tail skin temperatures in saline-injected rats kept with an oxytocin-injected rat suggested that the rats were physiologically affected through olfactory stimulation. The aim of the present study was to investigate the effect of olfactory cues from an oxytocin-treated male rat on the response to aversive stimulation in male conspecifics. Change in the rat's tail skin temperature was used as an indicator. The effect on the response of olfactory impairment was investigated by nasal ZnSO 4 infusion. Assuming an oxytocinergic mechanism was activated olfactorily, administration of an oxytocin antagonist was used to investigate whether the effect could be blocked.
Material and Methods
Animals and housing conditions: Male SpragueDawley rats (250 g, B&K Universal AB, Sollentuna) were kept in permanent groups of four (Table 1) and provided with food and water ad lib. The rats were housed and tested at four ambient temperatures between 18 and 25ºC, in a 12:12 h light:dark cycle, with lights on at 07.00 h.
Olfactory stimulation and drug treatments: Olfactory stimulation was accomplished by the exposure of three cagemates to the fourth oxytocin-injected rat kept in the same cage. The oxytocin-injected rats received a pharmacological dose (1 mg/kg, s.c.). The cagemates received injections of either saline or an oxytocin-antagonist (1-deamino-2-D-Tyr-(OEt)-4-Thr-8-Orn-oxytocin; Ferring AB; 1 mg/kg, s.c.). In control groups all rats in a cage received injections of one or the other of saline, oxytocin or the antagonist. Drugs were dissolved in saline, and all rats were injected subcutaneously with the same volume (1 ml/kg). Table 1 presents an overview of the experimental design.
Olfactory impairment: Impairment was obtained by nasal infusion of 0.05 cm 3 of a 5% ZnSO 4 solution under anesthesia (6% chloral hydrate, 2-2.5 ml/rat) 5 days before testing. 15 This method primarily impairs the olfactory mucosa 16 and thereby blocks the main olfactory bulb. Control animals received saline infusions. Time spent sniffing each of five different substances presented (apple, peanut butter, ethanol, acetic acid and a pungent sulphuric compound) was used to evaluate the blocking effect. The olfactorily impaired rats showed little interest when the substances were presented below their noses, spending only 1.6-2.6 s sniffing the various substances, compared with 3.6-6.8 s for the controls (Mann-Whitney U-test; U = 0-3, p < 0.001, n 1 = 11, n 2 = 12).
Aversive stimulation: Different forms of aversive or stressful stimulation were used, including s.c. injections compared with no injection, and repeated bouts of gentle immobilization while assessing the tail skin temperatures. Furthermore, the rats were tested at different ambient temperatures, and in a novel environment, respectivly.
Tail skin temperature assessment: The tail skin temperatures were assessed using a peltier element mounted on a plastic arm. The rats were held in a grip across the scapula while the element was rested on the dorsal surface of the tail 1 cm from the tail base for 30-60 s. Temperature assessments were repeated 4-6 times during training and pre-drug testing, and 6-13 times during the 120-150 min drug tests.
The rats were accustomed to handling and tail skin temperature assessments for 5 days prior to the drug tests. The tests took place in the afternoon and usually in the room where the rats were housed. When tested in an unfamiliar room the rats were not allowed to settle down. The experimenter had no knowledge of the drug treatment of individual rats.
Results

Effects of repeated tail skin temperature assessments without a prior s.c. injection:
Thirty-two rats were tested on two consecutive days with regard to their response to repeated tail skin temperature assessments. The rats did not recieve any drug or saline injection. Their tail skin temperature showed no significant increase over time (Fig. 1A) .
Effects of oxytocin, saline or oxytocin antagonist treatments on tail skin temperatures:
Following the injections and repeated assessments tail skin temperatures varied significantly over time in the oxytocin, antagonist and saline-injected rats (ANOVA, 2 = 11.4-20.9; p < 0.01-0.001). The tail skin temperature increased within 30 min after the injections compared with the pre-injection temperature ( Fig. 1C-F ; Sign test: 0.05-0.01), except in the rats brought into a novel environment just prior to the experiment (Fig. 1B) and those tested at a high (25ºC) ambient temperature (Fig 1D) . The temperatures dropped within 1 h of the increase in the oxytocin-treated rats ( Fig. 1B-F ; X = 0, n = 6-11, p = 0.05-0.01), but not in salinetreated (Fig. 1B-F) or oxytocin antagonist-treated rats (Fig. 1E ) without an oxytocin-injected cagemate. The return to pre-injection levels in these rats took more than 2 h.
Effects of stimuli from an oxytocin-injected rat on
cagemates' tail skin temperatures: A significant variation in tail skin temperature over time was also found in the saline-treated ( 2 = 15. ᮄ p < 0.001). A significant drop in tail skin temperatures was found in the saline-treated (Fig. 1C ,D: X = 0, n = 6, p = 0.05; F: X = 1, n = 9, p = 0.05), as well as in the oxytocin antagonist-injected cagemates (E: X = 0, n = 8, p = 0.01). The temperature variation in the saline-injected rats was synchronized to that in the oxytocin-injected rats' irrespective of the ambient temperature ( Fig. 1C-F ; linear regressions r = 0.72-0.86, significant in C and E, p = 0.03-0.01, but not in D: p = 0.11). The oxytocin antagonist-treated rats also showed a response synchronized to the oxytocintreated rats (Fig 1E; r = 0 .53, p = 0.08).
Effect of stimuli from an oxytocin-injected rat on olfactorily impaired cagemates' tail skin temperatures:
There was no drop, or synchronization of tail skin temperatures to the oxytocin-injected rats' in olfactorily impaired saline-injected cagemates (Fig 1F) of an oxytocin-injected rat.
Influence of different ambient temperatures, novel environment and s.c. injection on tail skin temperatures:
Pre-injection tail skin temperatures correlated positively with ambient temperatures across experiments (Fig 2: n = 18 , y = 0.5x -10.3; r 2 = 0.95). Following the s.c. injections tail skin temperatures increased within 30 min. The magnitude of the tail skin temperature increases correlated negatively with ambient temperatures (Fig. 2 : n = 14, y = -0.059x 2 + 2.14x -16.77; r 2 = 0.97). Tail skin temperatures did not increase additionally in the rats tested at 25ºC, or in those brought into a novel environment just before testing (Fig. 1B) . The tail skin temperature of the latter returned to the pre-injection temperature observed in other rats tested at 21ºC (Figs 1B,2) .
Discussion
The results of the present study show that systemic oxytocin administration (1 mg/kg, s.c.) results in a drop in a rat's tail skin temperature irrespective of ambient temperature. Interestingly, the oxytocin administration to one rat in a cage also resulted in a decrease in the tail skin temperature in its cagemates which had not received oxytocin treatment. Such synchronization was absent in olfactorily impaired cagemate rats. This implies that olfactory stimulation was involved.
The positive correlation between the pre-injection tail skin and ambient temperatures found is consistent with the thermoregulatory function of the rat's tail. 5 The negative correlation between the magnitude Table 1 .
FIG. 2. Mean resting tail skin temperatures (TSTs) (+)
in the treatment groups before drug injections, and the tail skin temperature increases after the injections plotted against ambient temperatures. For further symbols see Table 1 . The resting tail skin temperatures correlated positively, and the tail skin temperature increases negatively with ambient temperatures.
of the tail skin temperature increases seen following s.c. injections and the ambient temperatures is consistent with an ambient temperature dependent change in metabolism. 7 When tested in a novel environment or at a high ambient temperature, no additional temperature increase occurred, since the rats were already stressed. At high ambient temperatures there is little additional adrenal medullary activation in response to thermal stressors. 17 The stress-provoking effect of s.c. injections as such was implied by the lack of tail skin temperature increase in the tests without drug injections.
The temperature drop found in oxytocin antagonist-injected rats kept in the presence of an oxytocininjected cagemate suggest that an oxytocinergic mechanism was not involved in the rats' tail skin temperature response. However, it is consistent with the previous finding that the tail skin temperature reduction found in oxytocin injected rats is not antagonized, when oxytocin and the oxytocin antagonist 1-deamino-2-D-Tyr-(OEt)-4-Thr-8-Orn-oxytocin are administered s.c. in combination. 6 This antagonist can pass the blood-brain barrier, since its administration in a high dose (1 mg/kg) has been found to block other oxytocin-modulated responses. 18 A role of oxytocin in the tail skin temperature responses seen is still suggested by the fact that the hypothalamus is critically involved in temperature control and richly innervated by oxytocinergic fibers. 7, 19 At 8ºC, and to a reduced extent at 22ºC, central administration of oxytocin (4 g) into the preoptic anterior hypothalamus results in increased metabolism. 7 Central administration of oxytocin also resulted in decreased cutaneous temperatures at 22ºC and at 30ºC in conscious rats, thereby inducing hyperthermia, 7 indicating a reduced radiation energy loss.
Several reports have presented data suggesting a oxytocin dose-dependency with regard to external administration on stress and anti-stress effects. [8] [9] [10] 20, 21 Low doses of oxytocin have been associated with reduced physiological and behavioral responses to stress. While virgin rats, which have low levels of endogenous oxytocin, react to pups with aversion, 22 lactating females do not. 20 Several lines of evidence also suggest that the olfactory bulb is a critical site of oxytocin action with regards to gating the response to aversive stimuli. [11] [12] [13] [14] Thus, rapid onset and inhibition of maternal behavior, respectively, can be manipulated by intrabulbar infusion of oxytocin or its antagonist. 14 Therefore, oxytocin originating from the paraventricular nucleus was suggested to decrease olfactory processing at the level of the olfactory bulb, 13 and to facilitate onset of maternal behavior by gating the reaction to the aversive odours from newborn pups. 14 Assuming a similar mechanism is involved in the saline-injected rats kept with an oxytocin-injected cagemate in this study, this requires endogenous release induced by olfactory stimuli from the oxytocin-injected rat. Interestingly, it has recently been concluded that the most plausible explanation for the acquisition of a preference for maternally associated odors in rat pups involves endogenous oxytocin release, 23 since the response was blocked by intracranial injections (500 ng) of an oxytocin antagonist, d(CH2)[tyr(Me2,Thr4,Tyr(NH9)2]-ornithine vasotocin. In view of these findings, the results of our study suggest that the administration of oxytocin may induce pheromone release and olfactory signalling in the male rats which mimics the maternal odor of a lactating female. 24 This specific olfactory signal may then induce endogenous oxytocin release which results in stress reduction in the responders, in this case adult male rats. This renders the mechanism a generality beyond mother-offspring interaction.
In conclusion, we suggest that the tail skin temperature drop seen in saline-injected cagemates of an oxytocin-injected rat in this study is related to olfactorily stimulated oxytocin release in the olfactory bulb, which induces stress reduction. 13, 14 Further testing of this hypotheses is presently in progress.
Conclusion
Rats thermoregulate via the naked tail. Following s.c. injections tail skin temperatures increase due to a stress reaction. The present study demonstrated a temperature drop within 1 h in saline-injected rats exposed to olfactory cues from an oxytocin-injected cagemate, but not in saline-injected control rats. Under the same conditions the tail skin temperature responses of olfactorily impaired saline-injected rats did not decrease. These results show that major physiological effects, such as stress reduction, can be induced without specific drug administration via olfactory input from conspecifics.
